Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy.
Chronic Hyperkalemia in Cardiorenal Patients : Risk Factors, Diagnosis, and New Treatment Options / L. Di Lullo, C. Ronco, A. Granata, E. Paoletti, V. Barbera, M. Cozzolino, M. Ravera, M. Fusaro, A. Bellasi. - In: CARDIORENAL MEDICINE. - ISSN 1664-3828. - 9:1(2019 Jan), pp. 8-21. [10.1159/000493395]
Chronic Hyperkalemia in Cardiorenal Patients : Risk Factors, Diagnosis, and New Treatment Options
M. Cozzolino;
2019
Abstract
Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy.File | Dimensione | Formato | |
---|---|---|---|
Hyperkalemia CRM 2018.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
437.65 kB
Formato
Adobe PDF
|
437.65 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.